Research programme: tetrahydrofolate dehydrogenase inhibitors - Motif BioAlternative Names: DHFR inhibitor - Motif Bio; Dihydrofolate reductase inhibitors - Motif Bio; MTF-001
Latest Information Update: 03 Aug 2015
At a glance
- Originator Motif Bio
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Bacterial infections
Most Recent Events
- 23 Jun 2015 Preclinical trials in Bacterial infections in United Kingdom (PO)
- 23 Jun 2015 Preclinical trials in Bacterial infections in United Kingdom (IV)